ASH 41st (2000)

Drupal spam blocked by CleanTalk.
Title Content type
PHASE II TRIAL OF ALL-TRANS RETINOIC ACID (ATRA) IN THE TREATMENT OF RELAPSED/REFRACTORY MYCOSIS FUNGOIDES/SEZARY SYNDROME (MF/SS). (click for details)
EARLY DIAGNOSIS OF ADENOVIRUS INFECTION AND TREATMENT WITH CIDOFOVIR AFTER BONE MARROW TRANSPLANTATION IN CHILDREN. (click for details)
BONE MARROW TRANSPLANTATION (BMT) FOR PATIENTS WITH CHAGAS' DISEASE. (click for details)
RISK FACTORS FOR THROMBOTIC THROMBOCYTOPENIC PURPURA-HEMOLYTIC UREMIC SYNDROME (TTP-HUS) FOLLOWING BONE MARROW TRANSPLANTATION (BMT). (click for details)
MONITORING OF THE ACTIVITY OF INTERSTITIAL PNEUMONITIS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES USING SERUM K16-6. (click for details)
RISK FACTOR ANALYSIS FOR SURVIVAL AND GRAFT VERSUS HOST DISEASE IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA SUBMITTED TO ALLOGENEIC BONE MARROW TRANSPLANTATION. (click for details)
HIGH DOSE THERAPY FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) FOR PATIENTS WITH PRIMARY REFRACTORY HODGKIN'S DISEASE (HD): EVALUATION OF PROGNOSTIC FACTORS. (click for details)
REDUCED TOXICITY AND TRANSPLANT RELATED MORTALITY (TRM) FOLLOWING NONMYELOABLATIVE ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION FOR MALIGNANT DISEASES. (click for details)
AEROSOLIZED AMPHOTERICIN-B AS EFFECTIVE PROPHYLAXIS OF PULMONARY ASPERGILLOSIS IN PATIENTS WITH ACUTE LEUKEMIA. (click for details)
PROSPECTIVE SERIAL EVALUATION OF SERUM GALACTOMANNAN (GM) IN NEUTROPENIC PATIENTS AT RISK FOR INVASIVE ASPERGILLOSIS (IA): DIAGNOSTIC VALUE AND IMPACT ON CLINICAL PRACTICE. (click for details)

Pages

Subscribe to ASH 41st (2000)